XRCC4 and cancer: Large studies on the role of XRCC4 single-nucleotide polymorphisms (SNPs) in cancer susceptibility have been performed in hepatocellular carcinoma [17], lung cancer [18], multiple myeloma [19], and oral cancer [20].